1. Home
  2. YSG vs TOI Comparison

YSG vs TOI Comparison

Compare YSG & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YSG

Yatsen Holding Limited

HOLD

Current Price

$3.32

Market Cap

288.0M

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$5.12

Market Cap

512.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YSG
TOI
Founded
2016
2007
Country
China
United States
Employees
N/A
641
Industry
Package Goods/Cosmetics
Medical/Nursing Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.0M
512.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
YSG
TOI
Price
$3.32
$5.12
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.67
AVG Volume (30 Days)
212.3K
1.7M
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.08
$30.15
Revenue Next Year
$9.45
$25.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.15
$2.02
52 Week High
$11.04
$5.58

Technical Indicators

Market Signals
Indicator
YSG
TOI
Relative Strength Index (RSI) 55.29 59.32
Support Level $3.30 $2.91
Resistance Level $4.39 $5.58
Average True Range (ATR) 0.32 0.40
MACD 0.01 -0.03
Stochastic Oscillator 70.86 65.80

Price Performance

Historical Comparison
YSG
TOI

About YSG Yatsen Holding Limited

Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands. Geographically, company operates in PRC, Europe and US regions.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

Share on Social Networks: